Mabwell (Shanghai) Bioscience Co., Ltd. - B Stock: price and insider trades · Hong Kong

Mabwell (Shanghai) Bioscience Co., Ltd. - B is a Health Care company. Its directors and officers file their transactions with HKEX. 3 insiders have disclosed 5 filings since 22 October 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

For context, the typical company on the same exchange (median of 1,314 companies) published 4 filings over the same period, against 5 filings here.

No insider has bought Mabwell (Shanghai) Bioscience Co., Ltd. - B shares on the open market in the past twelve months. Between a trade and the moment it shows up on HKEX, the median delay is 15 days. Until a filing is published, the market cannot know about the trade.

Other companies in the same sector with recent insider buying flagged by our signals: UCB. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.